Literature DB >> 6784808

Leucocyte cation transport in essential hypertension: its relation to the renin-angiotensin system.

R P Edmondson, G A MacGregor.   

Abstract

Leucocyte cation transport measured when patients received a normal sodium intake and the response of the renin-angiotensin system to changes in sodium intake were studied in 22 patients with essential hypertension. The rate constant for total leucocyte sodium efflux measured during a normal diet was significantly correlated with the plasma renin activity measured during a low sodium diet. Impairment of leucocyte sodium transport was significantly greater in eight patients whose plasma renin activity failed to rise into the normal range during the low sodium diet as compared with the 14 other patients, whose renin system responded normally to sodium restriction. These results provide further suggestive evidence for the hypothesis that there is a circulating sodium transport inhibitor that may be important in the pathogenesis of essential hypertension.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6784808      PMCID: PMC1505350          DOI: 10.1136/bmj.282.6272.1267

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  16 in total

1.  Altered sodium permeability, calcium binding and Na-K-ATPase activity in the red blood cell membrane in essential hypertension.

Authors:  Y V Postnov; S N Orlov; A Shevchenko; A M Adler
Journal:  Pflugers Arch       Date:  1977-11-23       Impact factor: 3.657

Review 2.  The role of humoral agents in volume expanded hypertension.

Authors:  F J Haddy; H W Overbeck
Journal:  Life Sci       Date:  1976-10-01       Impact factor: 5.037

3.  Estimation of angiotensin II concentration in human plasma by radioimmunoassay. Some applications to physiological and clinical states.

Authors:  G Düsterdieck; G McElwee
Journal:  Eur J Clin Invest       Date:  1971-11       Impact factor: 4.686

Review 4.  Low-renin hypertension.

Authors:  M J Dunn; R L Tannen
Journal:  Kidney Int       Date:  1974-05       Impact factor: 10.612

5.  Humoral transmission of hypertension: evidence from parabiosis.

Authors:  L K Dahl; K D Knudsen; J Iwai
Journal:  Circ Res       Date:  1969-05       Impact factor: 17.367

6.  Body-fluid volume in low-renin hypertension.

Authors:  M A Schalekamp; M Lebel; D G Beevers; R Fraser; G Kolsters; W H Birkenhäger
Journal:  Lancet       Date:  1974-08-10       Impact factor: 79.321

7.  Sodium and potassium flux rates in normal human leucocytes in an artificial extracellular fluid.

Authors:  P J Hilton; J Patrick
Journal:  Clin Sci       Date:  1973-05       Impact factor: 6.124

8.  Measurement of plasma renin activity by radioimmunoassay after prolonged cold storage.

Authors:  J E Roulston; G A MacGregor
Journal:  Clin Chim Acta       Date:  1978-08-15       Impact factor: 3.786

Review 9.  Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis.

Authors:  M P Blaustein
Journal:  Am J Physiol       Date:  1977-05

10.  Abnormal leucocyte composition and sodium transport in essential hypertension.

Authors:  R P Edmondson; R D Thomas; P J Hilton; J Patrick; N F Jones
Journal:  Lancet       Date:  1975-05-03       Impact factor: 79.321

View more
  5 in total

1.  Hypertension symposium: newer topics on normal and abnormal blood pressure regulatory mechanisms.

Authors:  M L Tuck; M S Golub; P Eggena; J R Sowers; M Maxwell
Journal:  West J Med       Date:  1983-08

Review 2.  Circulating digitalis-like factors.

Authors:  V M Buckalew
Journal:  Pediatr Nephrol       Date:  1988-04       Impact factor: 3.714

3.  Dietary sodium and arterial pressure: problems of studies within a single population.

Authors:  G C Watt; C J Foy
Journal:  J Epidemiol Community Health       Date:  1982-09       Impact factor: 3.710

4.  Prostaglandin excretion after furosemide in normal and low-renin essential hypertension.

Authors:  B Scherer; H Witzgall; P C Weber
Journal:  Klin Wochenschr       Date:  1984-08-16

5.  Evidence for a raised concentration of a circulating sodium transport inhibitor in essential hypertension.

Authors:  G A MacGregor; S Fenton; J Alaghband-Zadeh; N Markandu; J E Roulston; H E de Wardener
Journal:  Br Med J (Clin Res Ed)       Date:  1981-11-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.